MoneyWorks4Me

Kerala Ayurveda Ltd (530163)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530163 NSE: Pharmaceuticals & Drugs | Small Cap | Kerala Ayurveda Share Price

₹158.05 -8.10 (-4.88%)

As on 25-Sep'26 16:59

Kerala Ayurveda Ltd (530163)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530163 NSE: Pharmaceuticals & Drugs | Small Cap | Kerala Ayurveda Share Price

₹158.05 -8.10 (-4.88%)

As on 25-Sep'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹205 Cr.
Current Price
₹158.1
52-Week Low / High
₹145 / 485
TTM EPS
₹-20.4
TTM Sales
₹136 Cr.
Book Value per Share
₹-15.5
P/E Ratio
0.00
Industry PE
54.9
Price to Book (P/B)
-10.18
Lower than its 5-year historical median
Price to Sales (P/S)
1.51
Lower than its 5-year historical median
EV/EBITDA
-22.63
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
-86.43%
Underperforms industry median
Return on Capital Employed (ROCE)
-8.94%
Underperforms industry median
Return on Assets (ROA)
-10.55%
Operating Profit Margin
-4.1%
Net Profit Margin
-11.6%
Gross Profit Margin
-5.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-0.62%
Operating Profit Growth (1 Year)
-
-173.96%
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
35.61%
Pledged shares (%) of Promoter's holding (%)
20.35%
Reserves
₹-33 Cr.
Equity
₹13 Cr.
Face Value
₹10
All Time Low / High
₹1.40 / 625.00

Kerala Ayurveda stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Fair

Price Trend

Weak
Q.1 Is Kerala Ayurveda Ltd a good quality company?
Kerala Ayurveda Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Kerala Ayurveda Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Kerala Ayurveda Ltd vs industry peers?
Kerala Ayurveda Ltd revenue CAGR is 9.40%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Kerala Ayurveda Ltd?
Promoters hold 35.61% of the Kerala Ayurveda Ltd, with 20.35% of their stake pledged, indicating high pledge risk.
Q.1 Stock return of Kerala Ayurveda Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 8.6% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Kerala Ayurveda Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ4.6%6%7%5.1%3.7%-0.6%10.2%9.9%5%-10.6%-
Value Creation
Index ⓘ
-0.7-0.6-0.5-0.6-0.7-1.0-0.3-0.3-0.6-1.8-

Growth Parameters ⓘ

Sales ⓘ32.639.643.846.553.743.255.863.373.172.790
Sales YoY Gr.-21.7%10.5%6.2%15.5%-19.5%29.2%13.4%15.6%-0.6%-
Adj EPS ⓘ1.62.12.20.30.8-4.70.80.9-0.2-12.5-18.8
YoY Gr.-27.4%4.3%-86.7%186.2%-665.1%NA2.4%-125.6%NA-
BVPS (₹) ⓘ14.914.116.712.8116.77.811.132.615.722.2
Adj Net
Profit ⓘ
1.72.22.30.30.9-50.90.9-0.3-15.1-24
Cash Flow from Ops. ⓘ2.51.5-10.99.34.7-0.98.89.1-4.22.3-
Debt/CF from Ops. ⓘ25.933.9-6.4612.3-72.377-14.723.8-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ9.3%6.3%9.2%-0.6%
Adj EPS ⓘ-225.4%-272.1%-346.2%NA
BVPSⓘ0.6%7.3%26.2%-51.8%
Share Price 8.6% 20.9% 8.1% -63.6%

Key Financial Parameters ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ
11.714.514.226.2-40.18.47.1-0.9-44.7-99.5
Op. Profit
Mgn % ⓘ
12.612.112.96.55.80.513.97.56.9-17.3-25.1
Net Profit
Mgn % ⓘ
5.35.65.30.71.6-11.51.61.4-0.4-20.7-27.1
Debt to
Equity ⓘ
4.13.53.94.259.47.45.51.62.9-
Working Cap
Days ⓘ
543432415421329422320283285315165
Cash Conv.
Cycle ⓘ
839910510794112797288120-21

Valuation of Kerala Ayurveda - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.0013.3613.3613.3613.3620.6923.5623.5620.3520.35
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales4650566277628093108120
Operating Expenses ⓘ + 3943485769617191101125
Manufacturing Costs666898119118
Material Costs89911121314171819
Employee Cost 14161821242222283454
Other Costs ⓘ 11121417241924373844
Operating Profit ⓘ 7785711037-5
Operating Profit Margin (%) 15.5%14.4%14.5%7.8%9.6%1.4%11.9%2.8%6.3%-4.2%
Other Income ⓘ + 1001000012
Exceptional Items ⓘ 0001001300
Interest ⓘ 2123267554
Depreciation ⓘ 2221111115
Profit Before Tax ⓘ 44435-73-11-12
Tax ⓘ 11110-20-022
Profit After Tax 33334-52-0-1-14
PAT Margin (%) 6.0%6.5%5.2%4.1%5.3%-7.8%3.0%-0.5%-0.8%-11.6%
Adjusted EPS (₹)2.62.92.72.33.7-4.62.2-0.5-1.3-12.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + -67848366323
Share Capital ⓘ 10.5610.5610.5610.5610.5610.5610.5610.5612.0312.03
Reserves ⓘ -17-4-3-7-3-7-4-520-9
Debt +69567562647770746864
Long Term Debt52204350525937505918
Short Term Debt1636321212183323846
Minority Interest1122222233
Trade Payables3344768886
Others Liabilities ⓘ 6121421222624263048
Total Liabilities ⓘ 738110392103114110115141124

Fixed Assets

Net Fixed Assets ⓘ +34343233333344464647
Gross Block49515152335567707177
Accumulated Depreciation1517191902223242531
CWIP ⓘ 06111214144779
Investments ⓘ 0000000000
Inventories6101012131112121613
Trade Receivables4557111013131619
Cash Equivalents 237561934233
Others Assets ⓘ 26233724262733323432
Total Assets ⓘ 738110392103114110115141124
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 64-101257-11025
PBT ⓘ 64466-0946-12
Adjustment ⓘ 222-71211115
Changes in Working Capital ⓘ -2-1-1515-26-115-45
Tax Paid ⓘ 0-0-0-1-000-0-1-2
Cash Flow From Investing Activity ⓘ + -3-3-3-3-4-1-2-7-1-15
Capex -3-2-5-2-3-1-3-6-1-13
Net Investments 0-000000000
Others ⓘ 0-22-1-1-01-1-0-1
Cash Flow From Financing Activity ⓘ + -3017-1216-13-118-9
Net Proceeds from Shares ⓘ 00000000280
Net Proceeds from Borrowing ⓘ -11237314-211390
Interest Paid ⓘ -2-1-2-2-2-6-7-5-4-4
Dividend Paid ⓘ 0000000000
Others ⓘ 00-4-16-0-114-10-15-5
Net Cash Flow ⓘ -014-2212-16218-19
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/A862.5438.7243.3993.9-183.03137.66-14.76-5.44-86.43
ROCE (%)N/A8.918.887.649.27-0.4512.626.186.75-8.94
Asset Turnover Ratio0.680.70.640.640.790.570.720.830.840.95
PAT to CFO Conversion(x)21.33-3.3341.25N/A-0.5N/AN/AN/A
Working Capital Days
Receivable Days29.7030.4031.8036.2041.9061.9053.8051.4048.7051
Inventory Days45.505362.4064.705870.1052.2047.8047.4041.40
Payable Days142123.70142.10134.70164.30186.10183.20169155.70128.90

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Kerala Ayurveda Ltd FAQs

The current trading price of Kerala Ayurveda on 25-Sep-2026 16:59 is ₹158.1.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Sep-2026 the market cap of Kerala Ayurveda stood at ₹205.4 Cr

The latest P/E ratio of Kerala Ayurveda as of 24-Sep-2026 is 0.00.

The latest P/B ratio of Kerala Ayurveda as of 24-Sep-2026 is 7.14.

The 52-week high of Kerala Ayurveda is ₹484.9 and the 52-week low is ₹145.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Kerala Ayurveda is ₹90.45 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Kerala Ayurveda Ltd is a below average quality company.

The key valuation ratios of Kerala Ayurveda Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Kerala Ayurveda Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Kerala Ayurveda Ltd

Kerala Ayurveda Ltd. (KAL) was founded on the banks of river Periyar at Aluva, Kochi, Kerala in 1945 by Late Vaidyan K G K Panicker, the renowned Ayurvedacharya. He was a doyen in Ayurvedic system, a visionary and a mentor. Now, more than half a century later, his inspired creation epitomizes all that is modern and state-of-the-art in Ayurveda. A leading Ayurvedic company today, KAL is backed by advanced technology and highly qualified dedicated staff.

Today Kerala Ayurveda is a major force in healthcare, growing at a spectacular rate -- with new clinics, new market strategies, new products, and new cures. Some of KAL's products are on the verge of being patented. KAL is truly on a mission to be the number one choice in Ayurveda globally.

Kerala Ayurveda has its world class manufacturing facility at Aluva, near Kochi. It also has a Herbarium.

The R&D Division of KAL has a prestigious herbal garden, which is actually a gene pool with more than 1200 species of rare and endangered medicinal plants, collected by conducting extensive surveys. These efforts also include certain hitherto unexplored tribal pockets, which are treasure groves of herbal wealth.

KAL has started its own Ayurvedic training center in view of propagating authentic Ayurveda. The training center, called KAL HRD CENTER is functioning as an annex to KAL Ayurveda Hospital at Aluva, near Kochi in Kerala. The center is easily assessable since it is located about 10 km, from the Nedumbassery International Airport (Cochin).The center is well equipped and conducts various training programme, various training Programs related with Ayurveda are offered by KAL HRD Center.

Publication Division- KAL has set up a publication division to publish Ayurvedic materials. An Ayurvedic quarterly journal named and styled as KAL VAIDYAM is published by this division. The division is designed to publish books, audio and video CDs and tapes on Ayurveda for the public and the scientific community.

Different offerings of the company:

  • Classical Medicines- These are formulations manufactured based on the Ayurvedic Formulatory of India. This is developed from 3000 years old scriptures. In KAL they  follow the traditional method for manufacturing these products.
  • Proprietary Medicines- These medicines are manufactured based on the formulas developed by KAL R&D division. The products are clinically tested by clinical trial, animal trial, etc before being launched in the market.
  • Katrasoft- Katrasoft is the technology division of Katra group, a multinational company with diverse business intrests in over 15 domains and investments in over 20 companies. Katrasoft operates as a division of Kerala Ayurveda Limited, one of the oldest names in Ayurveda, which is a listed company owned by Katra group.
  • Katra Nursing- Katra Nursing, one of the divisions of Katra Healtcare Pvt.Ltd. is a fast growing healthcare organization centered in Bangalore, India focussed in the training program of CGFNS, NCLEX and IELTS. The primary objective of the organization is to be a one-stop solution provider for nursing fraternity by exploring the best opportunities availble for KAL's nurses.

Achievements/ recognition:

KAL Hospital, Aluva has been accredited with “Green Leaf” certification by Department of Tourism, Government of Kerala, which is the highest classification for outstanding quality of facilities and services.

You have 41 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now